|
Volumn 8, Issue 4, 2008, Pages 209-
|
Trials and tribulations of antibiotic development
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIBIOTIC AGENT;
FROPENEM;
PLACEBO;
SIALIDASE INHIBITOR;
TELITHROMYCIN;
ANTIBIOTIC RESISTANCE;
ANTIBIOTIC THERAPY;
BRONCHITIS;
CHRONIC BRONCHITIS;
CLINICAL TRIAL;
COMMUNITY ACQUIRED PNEUMONIA;
DRUG APPROVAL;
DRUG EFFICACY;
DRUG INDICATION;
DRUG INDUSTRY;
DRUG MARKETING;
DRUG RESEARCH;
DRUG SAFETY;
EDITORIAL;
FOOD AND DRUG ADMINISTRATION;
HUMAN;
INFLUENZA;
MEDICAL SOCIETY;
METHODOLOGY;
PRIORITY JOURNAL;
PUBLIC HEALTH;
RISK BENEFIT ANALYSIS;
SINUSITIS;
STREPTOCOCCUS PNEUMONIAE;
ANTI-BACTERIAL AGENTS;
BACTERIA;
CLINICAL TRIALS AS TOPIC;
COMMUNITY-ACQUIRED INFECTIONS;
DRUG APPROVAL;
DRUG EVALUATION;
DRUG RESISTANCE, BACTERIAL;
HUMANS;
RESPIRATORY TRACT INFECTIONS;
|
EID: 40749097343
PISSN: 14733099
EISSN: None
Source Type: Journal
DOI: 10.1016/S1473-3099(08)70046-X Document Type: Editorial |
Times cited : (4)
|
References (0)
|